TARO-DOXORUBICIN LIPOSOMAL
Analogs of TARO-DOXORUBICIN LIPOSOMAL
Find cheaper analogs and generic equivalents for TARO-DOXORUBICIN LIPOSOMAL.
Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Product Overview
About TARO-DOXORUBICIN LIPOSOMAL
TARO-DOXORUBICIN LIPOSOMAL is a liposomal formulation of doxorubicin hydrochloride, a chemotherapeutic agent used in the treatment of various types of cancer. This medication is designed to deliver the active ingredient directly to the tumor site, reducing the risk of side effects and improving treatment outcomes.
Key Benefits & Uses
- Treatment of breast cancer, ovarian cancer, and AIDS-related Kaposi's sarcoma
- Combination therapy for the treatment of multiple myeloma and soft tissue sarcoma
- Palliative treatment of advanced breast cancer and other malignancies
Active Ingredient & Action
Doxorubicin hydrochloride is an anthracycline antibiotic that works by intercalating DNA strands, thereby inhibiting the synthesis of nucleic acids and inducing apoptosis in cancer cells. The liposomal formulation of TARO-DOXORUBICIN LIPOSOMAL helps to prolong the circulation time of the drug and increase its accumulation in tumor tissues.
Important Notes
Before using TARO-DOXORUBICIN LIPOSOMAL, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. Regular blood tests and liver function tests are necessary to monitor the effects of the medication. TARO-DOXORUBICIN LIPOSOMAL may cause cardiotoxicity, myelosuppression, and other side effects; therefore, patients should follow the recommended dosage and administration schedule carefully.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.